Neurologic conditions, such as epilepsy, migraine, and stroke, often have real-world consequences, such as those described in three new studies.
Mark L. Fuerst
Three new studies on multiple sclerosis discuss potential ways to prevent the development of cognitive problems, or the development of the disease.
Risk factors regarding MS, including genetic research findings and progressive multifocal leukoencephalopathy while taking natalizumab, are discussed.
Neuropsychological deficits often remain undiscovered during routine clinical examinations of multiple sclerosis patients due to time constraints.
New findings regarding viruses and neuronal cells could provide clues for possible new therapies for MS and Alzheimer disease.
The risks and benefits of intravenous tissue plasminogen activator and endovascular thrombectomy are discussed in the following slides.
The following slides discuss strokes: the role of job stress and the stress doctors feel when treating cryptogenic strokes.
A blood lipid could hold the keys to diagnosing migraines.
How do you prescribe triptans – generic meds, as monotherapy, via injection? Learn the best approach for your migraine patients.
Researchers investigate the 2-year and long-term results of resective surgery in children under 4 years old with epilepsy.